PharmaCielo Ltd. (OTCMKTS:PCLOF) Sees Large Growth in Short Interest

PharmaCielo Ltd. (OTCMKTS:PCLOF) was the target of a significant increase in short interest in the month of April. As of April 15th, there was short interest totaling 85,990 shares, an increase of 30.7% from the March 31st total of 65,776 shares. Based on an average trading volume of 113,875 shares, the short-interest ratio is presently 0.8 days.

PharmaCielo Trading Down 20.5%

Shares of PharmaCielo stock traded down $0.01 during trading hours on Wednesday, reaching $0.04. The stock had a trading volume of 155,951 shares, compared to its average volume of 68,082. The stock’s 50 day moving average is $0.04 and its 200 day moving average is $0.04. PharmaCielo has a twelve month low of $0.00 and a twelve month high of $0.12.

About PharmaCielo

PharmaCielo (OTCMKTS:PCLOF) is a Colombia-based, vertically integrated cannabinoid extraction and manufacturing company that develops pharmaceutical-grade active ingredients for the global medical cannabis market. The company specializes in the cultivation, extraction, purification and isolation of cannabinoids, producing a range of high-purity oils, distillates and isolates that serve as the active pharmaceutical ingredients (APIs) in end-use formulations. PharmaCielo’s product portfolio is designed to meet Good Manufacturing Practices (GMP) standards, enabling partnerships with pharmaceutical firms and wellness brands seeking compliant, consistently standardized cannabinoid inputs.

Since commencing operations, PharmaCielo has established a state-of-the-art extraction facility in Colombia, leveraging the country’s favorable agronomic conditions and regulatory framework for medicinal cannabis cultivation.